atezolizumab
roche
['nsclc', 'reassure', 'sclc', 'lcsm,(-blcsm)', 'atezo']
real patient oriented study in pts w poor performance and nsclc shows improved os with atezolizumab regardless of pd-l1 status was presented by dr siow ming lee #esmo2022 #esmo22. more importantly preserved qol and proms with atezo. reassures our clinical practice #lcsm
Regional Cancer Research Director @CleveClinicFl #Scientist #Immune #Oncology #Epigenetics #Cancer #Sensitisation #TIME #StayPositive. Tweets are mine.